Herein, the impact
of surface charge tailored of gold nanorods
(GNRs) on breast cancer cells (MCF-7 and MDA-MB-231) upon conjugation
with triphenylphosphonium (TPP) for improved photodynamic therapy
(PDT) targeting mitochondria was studied. The salient features of
the study are as follows: (i) positive (CTAB@GNRs) and negative (PSS-CTAB@GNRs)
surface-charged gold nanorods were developed and characterized; (ii)
the mitochondrial targeting efficiency of gold nanorods was improved
by conjugating TPP molecules; (iii) the conjugated nanoprobes (TPP-CTAB@GNRs
and TPP-PSS-CTAB@GNRs) were evaluated for PDT in the presence of photosensitizer
(PS), 5-aminolevulinic acid (5-ALA) in breast cancer cells; (iv) both
nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) induce apoptosis,
damage DNA, generate reactive oxygen species, and decrease mitochondrial
membrane potential upon 5-ALA-based PDT; and (v) 5-ALA-PDT of two
nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) impact cell signaling
(PI3K/AKT) pathway by upregulating proapoptotic genes and proteins.
Based on the results, we confirm that the positively charged (rapid)
nanoprobes are more advantageous than their negatively (slow) charged
nanoprobes. However, depending on the kind and degree of cancer, both
nanoprobes can serve as efficient agents for delivering anticancer
therapy.